Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19

22 Jul 2022

Abstract excerpt

Background: Similar pathogenesis makes Corona Virus Disease 2019 (COVID-19) associated with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and gouty arthritis (GA), and it is possible to introduce common drugs for the treatment of RA, AS and GA into the treatment of COVID-19. That is, “homotherapy for heteropathy”, especially cytokine inhibitors. But little is known about the specific link between the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammasome and immune disorders
Share to Pharmacological Effects of Natural Compounds
Share to Rheumatoid Arthritis Research and Therapies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35935817
DOI: 10.3389/fphar.2022.960267

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19PMID 35935817Read ↗

SARS-CoV-2 induces “cytokine storm” hyperinflammatory responses in RA patients through pyroptosisSemantic proximity Read ↗

Uncovering the underlying mechanisms of Compound Yuxingcao Mixture in the treatment of COVID-19 based on network pharmacologySemantic proximity Read ↗

Comprehensive bioinformatics analysis and systems biology approaches to identify the interplay between COVID-19 and pericarditisSemantic proximity Read ↗

Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methodsSemantic proximity Read ↗

Bioinformatics analysis of potential common pathogenic mechanisms for COVID-19 infection and primary Sjogren’s syndromeSemantic proximity Read ↗

Potential relationships between uveitis and COVID-19: a bioinformatic study based on CEO databaseSemantic proximity Read ↗

Exploration of Fuzheng Yugan Mixture on COVID-19 based on network pharmacology and molecular dockingSemantic proximity Read ↗

Examining the effector mechanisms of Xuebijing Injection on COVID-19 based on network pharmacologySemantic proximity Read ↗

“Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic StudySemantic proximity Read ↗

The Mechanism of Chaiyin Particles in the Treatment of COVID-19 Based on Network Pharmacology and Experimental VerificationSemantic proximity Read ↗

Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics AnalysisSemantic proximity Read ↗

SARS-CoV-2 intervened by NSAIDs: A network pharmacology approach to decipher signaling pathway and interactive genesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.